Pacific Coast Fetal Cardiology 2019 Symposium
March 29 - March 30
3rd Annual Pacific Coast Fetal Cardiology (PCFC) 2019: An Interactive and Case-Based Educational Symposium is organized by Children’s Hospital of Orange County (CHOC) and will be held from Mar 29 – 30, 2019 at Hyatt Regency Huntington Beach, Huntington Beach, California, United States of America. This CME Conference has been approved for a maximum of 10 AMA PRA Category 1 Credits™.
Radiologists, Maternal-Fetal Medicine, Pediatric Cardiologists need awareness and a better understanding of the new guidelines and lack the strategies or skills to apply this knowledge to their practice.
Experts in the field of fetal cardiology will teach healthcare professionals – who perform routine prenatal screenings – how to detect serious heart defects during pregnancy, as well as how to discern when to refer to a fetal cardiology specialist for further testing, counseling and intervention. Additionally, they will provide education on the current International Society for Ultrasound in Obstetrics and Gynecology (ISUOG) and American Society of Echocardiography (ASE) guidelines to increase screening efficacy and appropriate referrals to specialized prenatal imaging centers that provide appropriate life-saving care for these neonates.
One percent of infants born in the United States have heart defects, and 20 – 30 percent of these babies suffer from serious or life-threatening defects. According to the Centers for Disease Control and Prevention, more infants die in the United States from congenital heart disease than from any other birth defect. Routine prenatal screenings detect less than 35 percent of these defects, leaving them to be discovered only after birth and in many instances not until the infant becomes profoundly ill. Research has shown that prenatal detection rates for serious diseases can approach 90 percent when a rigorous population-based screening protocol, with grass roots sonographer education at its core, is used.
1. Create a high yield plan to counsel families for the inpatient and outpatient complexities surrounding CHD
2. Determine who and when to refer for intervention for hypoplastic left heart syndrome
3. Use suggested best practices and refined techniques for fetal cardiology screening
4. Rule out or assess for fetal arrhythmia and other causes of hydrops during fetal cardiology screening
5. Improve neurodevelopment outcomes by following suggested practices for a fetus with CHD
6. Develop strategies for the assessment of complex CHD with a focus on questions that effect treatment